The control group (N = 60) | The tranexamic acid group (N = 74) | P-value | ||
---|---|---|---|---|
Intraoperative | ||||
Blood transfusion rate | RCC | 50 (83.3) | 56 (75.7) | 0.39 |
FFP | 60 (100) | 68 (91.9) | 0.06 | |
PC | 0 (0) | 2 (2.7) | 0.50 | |
Blood transfusion volumea | RCC, mL | 840 [490 − 1120] | 560 [280 − 1120] | 0.07 |
FFP, mL | 1200 [960 − 1200] | 1200 [720 − 1200] | < 0.01* | |
PC, mL | 0 [0 − 0] | 0 [0 − 0] | 0.20 | |
Total volume of blood products, mL | 2040 [1480 − 2380] | 1560 [1000 − 2120] | 0.02* | |
Postoperative | ||||
Blood transfusion rate | RCC | 11 (18.3) | 17 (23.0) | 0.53 |
FFP | 24 (40.0) | 32 (43.2) | 0.73 | |
PC | 2 (3.3) | 2 (2.7) | 1.00 | |
Blood transfusion volume | RCC, mL | 0 [0 − 0] | 0 [0 − 0] | 0.46 |
FFP, mL | 0 [0 − 240] | 0 [0 − 480] | 0.35 | |
PC, mL | 0 [0 − 0] | 0 [0 − 0] | 0.81 | |
Total volume of blood products, mL | 0 [0 − 480] | 0 [0 − 550] | 0.27 |